D-1039-2017 Class III Terminated

Recalled by Teva Pharmaceuticals USA — North Wales, PA

FDA drug recall D-1039-2017 was initiated by Teva Pharmaceuticals USA on Jul 25, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: high out of specification results for related compound D. The recall status is terminated (terminated Apr 26, 2018). Affected quantity: 401,750 cartons.

Recall details

Product Type
Drugs
Report Date
Aug 9, 2017
Initiation Date
Jul 25, 2017
Termination Date
Apr 26, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
401,750 cartons

Product description

Albuterol Sulfate Inhalation Solution, 0.021% (0.63 mg/3mL), packaged in 5 pouches of 5 x 3mL Sterile Unit-Dose Vials For Inhalation per carton, Rx only, Mfd. for: Watson Laboratories, Inc., Corona, CA 92880; Mfd. by: Cipla Ltd., Verna, Goa INDIA, NDC 0591-3467-53.

Reason for recall

Failed Impurities/Degradation Specifications: high out of specification results for related compound D.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot #s: GA60206, GA60207, Exp 08/17; GA60283, GA60284, Exp 09/17; GA60378, GA60379, GA60478, Exp 10/17; GA60491, Exp 11/17; GA60615, GA60616, Exp 12/17; GA60719, GA60720, GA60721, GA60749, GA60750, GA60751, Exp 01/18; GA70001, GA70031, GA70046, GA70047, GA70074, GA70075, Exp 06/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1039-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1039-2017. Report a data issue: hello@regdatalab.com.